LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Cannabidiol in Neurology and Psychiatry
- 1st Edition, Volume 177 - July 17, 2024
- Editors: Elaine Del-Bel, Sabrina Francisca de Souza Lisbôa, Felipe V. Gomes
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 5 9 1 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 5 9 2 - 4
Cannabidiol in Neurology and Psychiatry, Volume 177 in the International Review in Neurobiology series, highlights new advances in the field, with this new volume presenting in… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteCannabidiol in Neurology and Psychiatry, Volume 177 in the International Review in Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on topic such as Historical perspective on the therapeutic potential of cannabidiol, Cannabidiol: pharmacodynamics pharmacokinetic, Cannabidiol and Alzheimer’s disease, Cannabidiol on anxiety disorders, Cannabidiol on psychosis, Cannabidiol on autism spectrum disorders, Cannabidiol in Epilepsy, Cannabidiol in Ischemia/stroke, Cannabidiol in Depression, Cannabidiol and Abuse of drugs, and much more.
Additional chapters cover Cannabidiol in fear response and PTSD, Cannabidiol and Pain. and Cannabidiol and Parkinson’s disease.
Additional chapters cover Cannabidiol in fear response and PTSD, Cannabidiol and Pain. and Cannabidiol and Parkinson’s disease.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in the International Review on Neurobiology series
- Updated release includes the latest information on Cannabidiol in Neurology and Psychiatry
Undergraduates, graduates, academics, and researchers in the field of Neurobiolog
- Cover image
- Title page
- Table of Contents
- Series Page
- Copyright
- Contributors
- Preface
- Chapter One: Historical perspective on the therapeutic potential of cannabidiol
- Abstract
- 1 Mechanisms of CBD effects
- 2 Conclusions and perspectives
- References
- Chapter Two: Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders
- Abstract
- 1 Introduction
- 2 Why has CBD emerged as a magical bullet in the neuropsychopharmacology scenario
- 3 Pharmacodynamics of CBD: multiple targets and bell-shaped dose response curve
- 4 Pharmacokinetics of cannabidiol: erratic absorption after oral administration
- 5 Nanobiotechnology applied to CBD’s pharmacology
- 6 Conclusion
- References
- Chapter Three: Cannabidiol and pain
- Abstract
- 1 Introduction
- 2 Pathophysiology of pain
- 3 The role of the endocannabinoid system in pain
- 4 CBD for musculoskeletal pain
- 5 CBD for neuropathic pain
- 6 Final remarks
- References
- Chapter Four: A journey through cannabidiol in Parkinson’s disease
- Abstract
- Abbreviations
- 1 Introduction
- 2 Dopamine: striatum neurotransmitters
- 3 The endocannabinoid system in the central nervous system: an outline
- 4 The phytocannabinoid cannabidiol
- 5 Conclusion and implications
- Acknowledgements
- References
- Chapter Five: Cannabidiol in experimental cerebral ischemia
- Abstract
- Abbreviations
- 1 Introduction
- 2 Cerebral ischemia
- 3 Preclinical models of cerebral ischemia
- 4 Pathophysiology of cerebral ischemia
- 5 Pharmacotherapy of ischemic cerebral injury
- 6 Cannabidiol
- 7 Cannabidiol and experimental models of cerebral ischemia
- 8 Conclusions
- Acknowledgments
- References
- Chapter Six: Cannabidiol and Alzheimer’s disease
- Abstract
- 1 Introduction
- 2 Rationale behind the use of Cannabidiol in Alzheimer’s disease: in vitro and pre-clinical evidence
- 3 Clinical evidence for the use of cannabidiol in Alzheimer’s disease
- 4 Conclusions
- Acknowledgments
- References
- Chapter Seven: Cannabidiol and epilepsy
- Abstract
- 1 Introduction
- 2 Epilepsy: concepts, mechanisms and treatment
- 3 CBD as an ASD
- 4 Mechanisms of action of CBD as an ASD
- 5 Conclusion
- References
- Chapter Eight: Therapeutic potential of CBD in Autism Spectrum Disorder
- Abstract
- 1 Introduction
- 2 Cannabis and endocannabinoid system
- 3 Involvement of the endocannabinoid system in ASD
- 4 Structure, pharmacological targets and preclinical studies that make CBD a potential candidate for ASD treatment
- 5 Clinical trials with phytocannabinoids in ASD context
- 6 The enteric microbiota in the context of ASD’s therapy by using cannabidiol
- 7 Final considerations
- References
- Chapter Nine: Cannabidiol in anxiety disorders: Current and future perspectives
- Abstract
- 1 Introduction
- 2 Clinical presentation of anxiety disorders
- 3 Pathophysiology
- 4 Current options for clinical management
- 5 Anxiolytic effects of CBD
- 6 Conclusions
- References
- Chapter Ten: Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies
- Abstract
- 1 Introduction
- 2 CBD effects in healthy humans and people with PTSD
- 3 CBD effects on fear memory acquisition and consolidation
- 4 CBD effects on fear memory reconsolidation
- 5 CBD effects on memory expression and fear extinction
- 6 Conclusion
- 7 Future directions
- References
- Chapter Eleven: Therapeutic potential of cannabidiol in depression
- Abstract
- 1 Introduction
- 2 Cannabidiol and depression
- 3 Mechanisms underlying cannabidiol’s antidepressant effect
- 4 Conclusion and perspectives
- References
- Chapter Twelve: Cannabidiol as an antipsychotic drug
- Abstract
- 1 Introduction
- 2 Preclinical studies
- 3 Clinical studies
- 4 Mechanisms of CBD antipsychotic effects
- 5 Conclusion
- References
- Chapter Thirteen: Cannabidiol and addiction
- Abstract
- 1 Introduction
- 2 CBD and SUD
- 3 Mechanisms
- 4 Conclusions and future directions
- References
- No. of pages: 350
- Language: English
- Edition: 1
- Volume: 177
- Published: July 17, 2024
- Imprint: Academic Press
- Hardback ISBN: 9780443235917
- eBook ISBN: 9780443235924
Read Cannabidiol in Neurology and Psychiatry on ScienceDirect